Data e luogo: 15 ottobre 2024 – Milano, Hotel Bianca Maria Palace (Viale Bianca Maria 4)
ECM/Residenziale: ID 2157- 425769 Accreditato presso la Commissione Nazionale per la Formazione Continua
Attribuiti 6 Crediti Formativi
Responsabili Scientifici: Giampaolo Bianchini, Carmen Criscitiello
Professioni accreditate: Medico Chirurgo (Discipline: Anatomia Patologica, Chirurgia Generale, Oncologia, Radioterapia, Radiodiagnostica), Biologo.
Razionale:
In the evolving landscape of breast cancer treatment, the integration of immunotherapy has significantly shifted paradigms, particularly in the management of triple-negative breast cancer (TNBC). This conference aims to delineate the role of neoadjuvant immunotherapy and its impact on surgical decision-making, focusing on early-stage TNBC. Emphasizing a multidisciplinary approach, the program is structured to enhance understanding of the nuances in surgical de-escalation, management of residual disease, and the maximization of pathological complete response (pCR) benefits.
